Home › Companies › ANIKA THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and ANIKA THERAPEUTICS INC.’s Form 8-K, filed June 24, 2025 (Item 5.07 on EDGAR). Page generated October 13, 2026.
Meeting of June 20, 2025: 6 items on ANIKA THERAPEUTICS INC.’s Form 8-K, filed June 24, 2025: 2 approved · 4 without a stated outcome.
Meeting of July 9, 2024: 5 items on ANIKA THERAPEUTICS INC.’s Form 8-K, filed July 11, 2024: 1 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens
Proxy season: 2024-2025 2025-2026
Explore ANIKA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ANIKA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. ANIKA THERAPEUTICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Cheryl R. Blanchard, Ph.D. | 8,754,717 | 2,139,215 | 51,074 | -- | 1,406,800 | 80% | Not verified | — |
| Elect Director: Joseph H. Capper | 10,521,730 | 387,385 | 35,891 | -- | 1,406,800 | 96% | Not verified | — |
| Elect Director: Glenn R. Larsen, Ph.D. | 8,712,940 | 2,202,441 | 29,625 | -- | 1,406,800 | 80% | Not verified | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 12,076,726 | 248,610 | 26,470 | -- | 0 | 98% | Approved | — |
| 3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and | 8,374,076 | 2,529,081 | 41,849 | -- | 1,406,800 | 77% | Not verified | — |
| 4. The Amendment with respect to the 2017 Plan | 8,297,563 | 2,608,925 | 38,518 | -- | 1,406,800 | 76% | Approved | — |
Source: ANIKA THERAPEUTICS INC., Form 8-K, filed with the SEC on June 24, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sheryl L. Conley | 10,713,825 | 415,055 | 27,858 | -- | 1,230,326 | 96% | Not verified | — |
| Elect Director: William R. Jellison | 11,092,818 | 13,085 | 50,835 | -- | 1,230,326 | 99.8% | Not verified | — |
| Elect Director: Stephen O. Richard | 10,205,467 | 924,213 | 27,058 | -- | 1,230,326 | 92% | Not verified | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 12,337,376 | 43,654 | 6,034 | -- | 0 | 99.6% | Approved | — |
| 3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and | 11,020,273 | 129,717 | 6,748 | -- | 1,230,326 | 99% | Not verified | — |
Source: ANIKA THERAPEUTICS INC., Form 8-K, filed with the SEC on July 11, 2024 — read the filing on EDGAR.
Each item below shows how the 186 asset managers that disclosed a ANIKA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Cheryl R. Blanchard, Ph.D.
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl R. Blanchard, Ph.D.”): 8,754,717 for, 2,139,215 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,269,969 for, 1,202 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Glenn R. Larsen, Ph.D.
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn R. Larsen, Ph.D.”): 8,712,940 for, 2,202,441 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,249,803 for, 21,368 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 24,278 | 19,250 | 0 | 0 | Mixed |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Joseph H. Capper
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph H. Capper”): 10,521,730 for, 387,385 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,250,659 for, 20,512 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 24,278 | 19,250 | 0 | 0 | Mixed |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Meeting held July 9, 2024.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: Stephen O. Richard
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Stephen O. Richard”): 10,205,467 for, 924,213 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 2,839,761 for, 379,792 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 147,890 | 0 | 0 | Against |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 129,315 | 0 | 0 | Against |
| SEI | 0 | 74,943 | 0 | 0 | Against |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 25,343 | 18,800 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,634 | 1 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held July 9, 2024.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: William R. Jellison
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: William R. Jellison”): 11,092,818 for, 13,085 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,219,553 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 44,143 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held July 9, 2024.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: Sheryl L. Conley
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sheryl L. Conley”): 10,713,825 for, 415,055 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 3,182,236 for, 20,003 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 25,343 | 18,800 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,634 | 1 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
| Legg Mason | 6,675 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Meeting held June 20, 2025.
76% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE AMENDMENT TO THE ANIKA THERAPEUTICS, INC. 2017 OMNIBUS INCENTIVE PLAN.
ANIKA THERAPEUTICS INC.’s own tally for this item (“4. The Amendment with respect to the 2017 Plan”): 8,297,563 for, 2,608,925 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 4 Stockholders approved the Amendment with respect to the 2017 Plan.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ANIKA THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (2 managers, 24,815 for).
The 52 asset managers below reported 2,062,782 for, 186,508 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 293,361 | 18,632 | 0 | 0 | Mixed |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 0 | 45,449 | 0 | 0 | Against |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 0 | 40,946 | 0 | 0 | Against |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,672 | 13,599 | 0 | 0 | Mixed |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,986 | 9,395 | 0 | 0 | Mixed |
| State Street | 72 | 10,436 | 0 | 0 | Against |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 5,917 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held July 9, 2024.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
ANIKA THERAPEUTICS INC.’s own tally for this item (“3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussi”): 11,020,273 for, 129,717 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 542,699 | 0 | 0 | 0 | For |
| Fidelity | 330,486 | 0 | 0 | 0 | For |
| TIAA | 164,865 | 0 | 0 | 0 | For |
| Charles Schwab | 142,079 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 71,873 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 32,448 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 3,177,935 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Trigran Investments, Inc. | 1,954,587 | 0 | 0 | 0 | For |
| Caligan Partners LP | 1,360,450 | 0 | 0 | 0 | For |
| BlackRock | 789,764 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 501,950 | 0 | 0 | 0 | For |
| Renaissance | 474,454 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 336,544 | 0 | 0 | 0 | For |
| State Street | 300,194 | 0 | 0 | 0 | For |
| Nuveen | 176,916 | 0 | 0 | 0 | For |
| DE Shaw | 154,955 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| Meros Investment Management, LP | 143,294 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 142,381 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL ADVISERS LLC | 129,315 | 0 | 0 | 0 | For |
| Northern Trust | 118,969 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 115,297 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 107,005 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 104,387 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 96,435 | 0 | 0 | 0 | For |
| Dimensional | 77,645 | 0 | 0 | 0 | For |
| SEI | 76,206 | 0 | 0 | 0 | For |
| Two Sigma | 71,977 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 71,197 | 0 | 0 | 0 | For |
| AQR | 64,345 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 60,309 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 50,680 | 0 | 0 | 0 | For |
Institutional-manager reports, all 122 managers: 8,187,408 for, 22,557 against, 1,448 abstained. Showing the 25 largest; see all in the interactive database.
Meeting held June 20, 2025.
Combines 7 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
ANIKA THERAPEUTICS INC.’s own tally for this item (“3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussi”): 8,374,076 for, 2,529,081 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Vanguard | 315,109 | 0 | 0 | 0 | For |
| Fidelity | 298,838 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| TIAA | 30,003 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 9,395 | 2,986 | 0 | 0 | Mixed |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 5,608 | 1,585 | 0 | 0 | Mixed |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 5,917 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 1,722,550 for, 55,156 against, 828 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Trigran Investments, Inc. | 1,938,455 | 0 | 0 | 0 | For |
| Caligan Partners LP | 0 | 1,434,130 | 0 | 0 | Against |
| BlackRock | 822,646 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 0 | 529,503 | 0 | 0 | Against |
| Opaleye Management Inc. | 490,888 | 0 | 0 | 0 | For |
| Renaissance | 362,194 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 331,538 | 0 | 0 | 0 | For |
| State Street | 187,732 | 0 | 0 | 0 | For |
| DE Shaw | 148,615 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| Meros Investment Management, LP | 111,056 | 0 | 0 | 0 | For |
| Northern Trust | 101,208 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 94,703 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 87,600 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 68,062 | 0 | 0 | 0 | For |
| Dimensional | 0 | 64,961 | 0 | 0 | Against |
| ENVESTNET ASSET MANAGEMENT INC | 47,753 | 1,563 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 48,733 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 45,449 | 0 | 0 | 0 | For |
| Wellington | 41,458 | 0 | 0 | 0 | For |
| Nuveen | 41,315 | 0 | 0 | 0 | For |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| Asset Management One Co., Ltd. | 33,780 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 31,641 | 0 | 0 | 0 | For |
| Citadel | 30,308 | 0 | 0 | 0 | For |
Institutional-manager reports, all 111 managers: 5,572,764 for, 2,077,853 against. Showing the 25 largest; see all in the interactive database.
Meeting held June 20, 2025.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
ANIKA THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 12,076,726 for, 248,610 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 2 Stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,271,110 for, 61 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,507 | 1 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Meeting held July 9, 2024.
Combines 3 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Ratification of appointment of Deloitte & Touche LLP as Anika's independent auditor for 2024; and
ANIKA THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 12,337,376 for, 43,654 against — passed, per its Form 8-K filed July 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 2 Stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,219,501 for, 52 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 44,143 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 14,839,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.16% |
| 2 | BlackRock | 3.94% |
| 3 | Fidelity | 2.10% |
| 4 | Charles Schwab | 0.92% |
| 5 | MFS | 0.31% |
| 6 | Equitable | 0.29% |
| 7 | TIAA | 0.28% |
| 8 | American Century | 0.26% |
| 9 | SEI | 0.20% |
| 10 | Columbia Threadneedle | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Trigran Investments, Inc. | 13.17% |
| 2 | Caligan Partners LP | 9.17% |
| 3 | BlackRock | 5.32% |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | 3.38% |
| 5 | Renaissance | 3.20% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.27% |
| 7 | State Street | 2.02% |
| 8 | Nuveen | 1.19% |
| 9 | DE Shaw | 1.04% |
| 10 | Charles Schwab | 1.00% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 10.24% | 13F |
| Caligan Partners LP | 9.67% | 13D |
| BlackRock, Inc. | 6.49% | 13G |
| Vanguard Group | 5.24% | 13F |
| Dimensional Fund Advisors | 4.14% | 13F |
| Renaissance Technologies | 3.56% | 13F |
| State Street | 2.20% | 13F |
| Trigran Investments, Inc. | 1.13% | 13G |
| D.E. Shaw | 1.13% | 13F |
| Charles Schwab | 1.01% | 13F |
Percentages above are of 14,839,000 shares outstanding, as reported by ANIKA THERAPEUTICS INC. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANIKA THERAPEUTICS INC.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.
At ANIKA THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held July 9, 2024 and June 20, 2025), 186 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 2,012 separate fund positions. On the most widely held item of the season, voted at the meeting held July 9, 2024 — ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANIKA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 11, 2024.
ANIKA THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.